390 related articles for article (PubMed ID: 22945471)
1. A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain-Barré syndrome.
Louwen R; Horst-Kreft D; de Boer AG; van der Graaf L; de Knegt G; Hamersma M; Heikema AP; Timms AR; Jacobs BC; Wagenaar JA; Endtz HP; van der Oost J; Wells JM; Nieuwenhuis EE; van Vliet AH; Willemsen PT; van Baarlen P; van Belkum A
Eur J Clin Microbiol Infect Dis; 2013 Feb; 32(2):207-26. PubMed ID: 22945471
[TBL] [Abstract][Full Text] [Related]
2. Campylobacter jejuni from patients with Guillain-Barré syndrome preferentially expresses a GD(1a)-like epitope.
Nachamkin I; Liu J; Li M; Ung H; Moran AP; Prendergast MM; Sheikh K
Infect Immun; 2002 Sep; 70(9):5299-303. PubMed ID: 12183587
[TBL] [Abstract][Full Text] [Related]
3. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
[TBL] [Abstract][Full Text] [Related]
4. Guillain-Barré syndrome-related Campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies.
Islam Z; Gilbert M; Mohammad QD; Klaij K; Li J; van Rijs W; Tio-Gillen AP; Talukder KA; Willison HJ; van Belkum A; Endtz HP; Jacobs BC
PLoS One; 2012; 7(8):e43976. PubMed ID: 22952833
[TBL] [Abstract][Full Text] [Related]
5. Co-infection with two different Campylobacter jejuni strains in a patient with the Guillain-Barré syndrome.
Godschalk PC; Gilbert M; Jacobs BC; Kramers T; Tio-Gillen AP; Ang CW; Van den Braak N; Li J; Verbrugh HA; Van Belkum A; Endtz HP
Microbes Infect; 2006 Jan; 8(1):248-53. PubMed ID: 16213180
[TBL] [Abstract][Full Text] [Related]
6. Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes.
Godschalk PC; Kuijf ML; Li J; St Michael F; Ang CW; Jacobs BC; Karwaski MF; Brochu D; Moterassed A; Endtz HP; van Belkum A; Gilbert M
Infect Immun; 2007 Mar; 75(3):1245-54. PubMed ID: 17261613
[TBL] [Abstract][Full Text] [Related]
7. Role of Campylobacter jejuni infection in the pathogenesis of Guillain-Barré syndrome: an update.
Nyati KK; Nyati R
Biomed Res Int; 2013; 2013():852195. PubMed ID: 24000328
[TBL] [Abstract][Full Text] [Related]
8. Are bacteriophage defence and virulence two sides of the same coin in Campylobacter jejuni?
Louwen R; van Baarlen P
Biochem Soc Trans; 2013 Dec; 41(6):1475-81. PubMed ID: 24256240
[TBL] [Abstract][Full Text] [Related]
9. Glycoconjugates play a key role in Campylobacter jejuni Infection: interactions between host and pathogen.
Day CJ; Semchenko EA; Korolik V
Front Cell Infect Microbiol; 2012; 2():9. PubMed ID: 22919601
[TBL] [Abstract][Full Text] [Related]
10. Ganglioside mimicry as a cause of Guillain-Barré syndrome.
Yuki N; Odaka M
Curr Opin Neurol; 2005 Oct; 18(5):557-61. PubMed ID: 16155440
[TBL] [Abstract][Full Text] [Related]
11. Identification of DNA sequence variation in Campylobacter jejuni strains associated with the Guillain-Barré syndrome by high-throughput AFLP analysis.
Godschalk PC; Bergman MP; Gorkink RF; Simons G; van den Braak N; Lastovica AJ; Endtz HP; Verbrugh HA; van Belkum A
BMC Microbiol; 2006 Apr; 6():32. PubMed ID: 16594990
[TBL] [Abstract][Full Text] [Related]
12. Low-Dose Exposure to Ganglioside-Mimicking Bacteria Tolerizes Human Macrophages to Guillain-Barré Syndrome-Associated Antigens.
Patry RT; Essler L; Andresen S; Quinn FD; Szymanski CM
mBio; 2021 Feb; 13(1):e0385221. PubMed ID: 35100875
[TBL] [Abstract][Full Text] [Related]
13. Campylobacter jejuni cst-II polymorphisms and association with development of Guillain-Barré syndrome.
Hye JB; Nachamkin I
Neurology; 2007 May; 68(19):1633-4. PubMed ID: 17485654
[No Abstract] [Full Text] [Related]
14. Characterization of the specific interaction between sialoadhesin and sialylated Campylobacter jejuni lipooligosaccharides.
Heikema AP; Bergman MP; Richards H; Crocker PR; Gilbert M; Samsom JN; van Wamel WJ; Endtz HP; van Belkum A
Infect Immun; 2010 Jul; 78(7):3237-46. PubMed ID: 20421384
[TBL] [Abstract][Full Text] [Related]
15. TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation.
Kuijf ML; Samsom JN; van Rijs W; Bax M; Huizinga R; Heikema AP; van Doorn PA; van Belkum A; van Kooyk Y; Burgers PC; Luider TM; Endtz HP; Nieuwenhuis EE; Jacobs BC
J Immunol; 2010 Jul; 185(1):748-55. PubMed ID: 20525894
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of lipo-oligosaccharide loci of Campylobacter jejuni isolates associated with Guillain-Barré Syndrome from Hebei, China.
Jiang H; Zhang MJ; Liu RC; Tian XY; Gu YX; Zhang JZ
Int J Mol Sci; 2010 Mar; 11(3):1155-61. PubMed ID: 20480006
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
Prendergast MM; Moran AP
J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
[TBL] [Abstract][Full Text] [Related]
18. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
Yuki N
J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
[TBL] [Abstract][Full Text] [Related]
19. Molecular mimicry in Campylobacter jejuni: role of the lipo-oligosaccharide core oligosaccharide in inducing anti-ganglioside antibodies.
Perera VN; Nachamkin I; Ung H; Patterson JH; McConville MJ; Coloe PJ; Fry BN
FEMS Immunol Med Microbiol; 2007 Jun; 50(1):27-36. PubMed ID: 17374131
[TBL] [Abstract][Full Text] [Related]
20. Campylobacter sialyltransferase gene polymorphism directs clinical features of Guillain-Barré syndrome.
Yuki N
J Neurochem; 2007 Nov; 103 Suppl 1():150-8. PubMed ID: 17986150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
